Article

(2023) Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients. Molecular Biology Reports. pp. 173-183. ISSN 0301-4851

(2023) RETRACTION: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response (Retraction of Vol 39, Pg 353, 2022). Pharmaceutical research. pp. 615-616. ISSN 0724-8741

(2023) Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. pp. 615-616. ISSN 1573-904X (Electronic) 0724-8741 (Linking)

(2023) Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response(Pharmaceutical Research, (2022), 39, (353-367), 10.1007/s11095-022-03169-2). Pharmaceutical research. pp. 615-616. ISSN 07248741 (ISSN)

(2023) The prognostic and therapeutic potential of HO-1 in leukemia and MDS. Cell communication and signaling : CCS. p. 57. ISSN 1478-811X (Electronic) 1478-811X (Linking)

(2022) Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. pp. 353-367. ISSN 0724-8741

(2022) Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharmaceutical research. ISSN 1573-904X (Electronic) 0724-8741 (Linking)

(2022) Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses. Life Sciences. p. 121008. ISSN 1879-0631 (Electronic) 0024-3205 (Linking)

(2022) Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharmaceutical research. pp. 1851-1866. ISSN 0724-8741

(2022) NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases. International Immunopharmacology. p. 13. ISSN 1567-5769

(2022) The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both? Frontiers in Immunology. p. 22. ISSN 1664-3224

(2022) Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models. Life Sciences. p. 12. ISSN 0024-3205

(2022) Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment. Progress in biophysics and molecular biology. pp. 3-14. ISSN 1873-1732 (Electronic) 0079-6107 (Linking)

(2022) A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation. Cell Biology International. pp. 1557-1570. ISSN 1065-6995

(2022) The molecular biology and therapeutic potential of Nrf2 in leukemia. Cancer Cell International. p. 24.

(2021) Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment. European journal of pharmacology. p. 174419. ISSN 1879-0712 (Electronic) 0014-2999 (Linking)

(2021) Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility. International Journal of Rheumatic Diseases. pp. 567-581. ISSN 1756-1841

(2021) Does CCL19 act as a double-edged sword in cancer development? Clinical and experimental immunology. ISSN 1365-2249 (Electronic) 0009-9104 (Linking)

(2021) Humoral immune mechanisms involved in protective and pathological immunity during COVID-19. Human Immunology. pp. 733-745. ISSN 0198-8859

(2021) Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2. Life Sciences. p. 11. ISSN 0024-3205

(2021) PD-1/PD-L1 Blockade: Prospectives for immunotherapy in Cancer and Autoimmunity. IUBMB life. ISSN 1521-6551 (Electronic) 1521-6543 (Linking)

(0000) The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives. Immunological Investigations. p. 27. ISSN 0882-0139

(UNSPECIFIED) The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies. Expert Opinion on Therapeutic Targets. p. 15. ISSN 1472-8222

(UNSPECIFIED) The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia. IUBMB life. p. 22. ISSN 1521-6543